PhoreMost, a UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, and Polaris Quantum Biotech, a North Carolina-based quantum computing drug design company, will collaborate to study oncology targets currently considered undruggable.

MolGen B.V., a provider of DNA / RNA extraction technology, has opened an office in London, UK. The new location will serve as a pivotal branch to provide laboratories in the UK with access to the company’s extraction DNA / RNA portfolio across diagnostics, pharma and the biotech industry. The opening of the London office […]

Insightful Science, a software company enabling the Cloud for Scientific Discovery, has acquired Protein Metrics, a leading provider of biopharmaceutical protein characterization and proteomics analysis software. The acquisition expands the company’s R&D value chain to widen the biopharmaceutical protein analysis arena, unblocking data analysis bottlenecks currently associated with large-scale protein studies.